These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 37242690)

  • 1. 3D Printing Technology as a Promising Tool to Design Nanomedicine-Based Solid Dosage Forms: Contemporary Research and Future Scope.
    Ahmad J; Garg A; Mustafa G; Mohammed AA; Ahmad MZ
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D Printing of Dapagliflozin Containing Self-Nanoemulsifying Tablets: Formulation Design and In Vitro Characterization.
    Algahtani MS; Mohammed AA; Ahmad J; Abdullah MM; Saleh E
    Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34209066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D Printing of Solid Oral Dosage Forms: Numerous Challenges With Unique Opportunities.
    Okafor-Muo OL; Hassanin H; Kayyali R; ElShaer A
    J Pharm Sci; 2020 Dec; 109(12):3535-3550. PubMed ID: 32976900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D printed tablets loaded with polymeric nanocapsules: An innovative approach to produce customized drug delivery systems.
    Beck RCR; Chaves PS; Goyanes A; Vukosavljevic B; Buanz A; Windbergs M; Basit AW; Gaisford S
    Int J Pharm; 2017 Aug; 528(1-2):268-279. PubMed ID: 28583328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials-Process Perspective.
    Azad MA; Olawuni D; Kimbell G; Badruddoza AZM; Hossain MS; Sultana T
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.
    Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F
    Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D Printing technologies for drug delivery: a review.
    Prasad LK; Smyth H
    Drug Dev Ind Pharm; 2016; 42(7):1019-31. PubMed ID: 26625986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.
    Serajuddin ATM
    ADMET DMPK; 2023; 11(1):33-55. PubMed ID: 36778904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.
    Alhnan MA; Okwuosa TC; Sadia M; Wan KW; Ahmed W; Arafat B
    Pharm Res; 2016 Aug; 33(8):1817-32. PubMed ID: 27194002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D printing hybrid materials using fused deposition modelling for solid oral dosage forms.
    Krueger L; Miles JA; Popat A
    J Control Release; 2022 Nov; 351():444-455. PubMed ID: 36184971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrusion-based 3D printing for development of complex capsular systems for advanced drug delivery.
    Algahtani MS; Ahmad J; Mohammed AA; Ahmad MZ
    Int J Pharm; 2024 Sep; 663():124550. PubMed ID: 39103062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D Printing Technology in Pharmaceutical Dosage Forms: Advantages and Challenges.
    Desu PK; Maddiboyina B; Vanitha K; Rao Gudhanti SNK; Anusha R; Jhawat V
    Curr Drug Targets; 2021; 22(16):1901-1914. PubMed ID: 33494666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Recent Review On 3D-Printing: Scope and Challenges with Special Focus on Pharmaceutical Field.
    Singh S; Kumar M; Doolaanea AA; Mandal UK
    Curr Pharm Des; 2022; 28(30):2488-2507. PubMed ID: 35747955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Critical Review on 3D-printed Dosage Forms.
    El Aita I; Ponsar H; Quodbach J
    Curr Pharm Des; 2018; 24(42):4957-4978. PubMed ID: 30520369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation and
    Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Graphical Review on the Escalation of Fused Deposition Modeling (FDM) 3D Printing in the Pharmaceutical Field.
    Melocchi A; Uboldi M; Cerea M; Foppoli A; Maroni A; Moutaharrik S; Palugan L; Zema L; Gazzaniga A
    J Pharm Sci; 2020 Oct; 109(10):2943-2957. PubMed ID: 32679215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veering to a Continuous Platform of Fused Deposition Modeling Based 3D Printing for Pharmaceutical Dosage Forms: Understanding the Effect of Layer Orientation on Formulation Performance.
    Kulkarni VR; Chakka J; Alkadi F; Maniruzzaman M
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.